Multiple Sclerosis Treatment History timeline

Jean-Martin Charcot Diagnoses Multiple Sclerosis

The French neurologist Jean-Martin Charcot (1825–1893) was the first person to recognize multiple sclerosis as a distinct disease in 1868.... Read more

The Disease Sclerose En Plagues's Name is Changed to Multiple Sclerosis

It was called sclerose en plagues until 1955 when the name was changed to Multiple Sclerosis. Read more

FDA Approves Pharmacia and UpJohn's Solu-Medrol Solution

Treating certain conditions associated with decreased adrenal gland function. It is also used to treat severe inflammation caused by certain... Read more

FDA Approves Bayer HealthCare's Betaseron to Treat Relapsing Forms of Multiple Sclearosis

BETASERON is indicated for the treatment of relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and is... Read more

Avonex Comes Out as a Drug to Treat Multiple Sclerosis

Avonex has been available since 1995. It is made by Biogen Idec. Avonex comes in new, prefilled syringes (called luer lock), which can be left... Read more

FDA Approves Teva's Copaxone to Reduce Frequency in Patients with Relapsing-Remitting Multiple Sclerosis

Copaxone is indicated for reduction of the frequency of relapses in patients with Relapsing-Remitting Multiple Sclerosis (RRMS), including patients... Read more

FDA Approves Cephalon's Provigil

So I mentioned this to my neurologist who gave me some samples of a medication to try. Those samples were for Provigil, a prescription medication... Read more

FDA Approves Immunex's Novantrone to Reduce Disability and the Number of Relapses in Patients with Multiple Sclerosis

Novantrone has been approved for use in reducing neurologic disability and/or the frequency of relapses in patients with secondary (chronic)... Read more

FDA Approves Pfitzer's Rebif for the Treatment of Relapsing Forms of Multiple Sclerosis

This March, the U.S. Food and Drug Administration (FDA) approved Rebif, a form of interferon beta-1a manufactured by Serono, for treatment of... Read more

FDA Approves Biogen's Tysabri

Tysabri is a monoclonal antibody that affects the actions of the body's immune system. Monoclonal antibodies are made to target and destroy only... Read more

FDA Approves Acorda's Ampyra

Ampyra, formerly known as fampridine SR, is a tablet containing a sustained-release formula of 4-aminopyridine, which blocks tiny pores, or... Read more